Company intelligence / Profile preview
Virano Therapeutics
Toronto and Ottawa, Ontario, Canadaviranotx.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Developing proprietary molecules that temporarily dampen the immune system to give virus-based cancer therapies a greater chance to take hold and fight cancer cells[4]
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Gene therapyimmune modulating small molecules (VEPOs™)combination products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Partnerships with global gene therapy players mentioned but not specified[2]
Beyond the preview
Go deeper on Virano Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virano Therapeutics.